Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Fitxers

669143.pdf (129.79 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2017-03

Llicència de publicació

cc-by (c) Dickmann, Petra et al., 2017
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/122829

Communicating the Risk of MRSA: The Role of Clinical Practice, Regulation and Other Policies in Five European Countries

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.3389/fpubh.2017.00044

Resum

The threat posed by Meticillin-resistant Staphylococcus aureus (MRSA) has taken on an increasingly pan-European dimension. This article aims to provide an overview of the different approaches to the control of MRSA adopted in five European countries (Austria, Germany, Netherlands, Spain, and the UK) and discusses data and reporting mechanisms, regulations, guidelines, and health policy approaches with a focus on risk communication. Our hypothesis is that current infection control practices in different European countries are implicit messages that contribute to the health-related risk communication and subsequently to the public perception of risk posed by MRSA.A reporting template was used to systematically collect information from each country. Large variation in approaches was observed between countries. However, there were a number of consistent themes relevant to the communication of key information regarding MRSA, including misleading messages, inconsistencies in content and application of published guidelines, and frictions between the official communication and their adoption on provider level. The variability of recommendations within, and across, countries could be contributing to the perception of inconsistency. Having inconsistent guidelines and practices in place may also be affecting the level at which recommended behaviors are adopted. The discrepancy between the official, explicit health messages around MRSA and the implicit messages stemming from the performance of infection control measures should, therefore, be a key target for those wishing to improve risk communication.

Matèries

Atenció primària, Infeccions per estafilococs, Factors de risc en les malalties, Control d'infeccions

Matèries (anglès)

Primary health care, Staphylococcal infections, Risk factors in diseases, Infection control

Citació

Col·leccions

Articles publicats en revistes (Economia)
Publicacions de projectes de recerca finançats per la UE

Citació

DICKMANN, Petra, et al. Communicating the Risk of MRSA: The Role of Clinical Practice, Regulation and Other Policies in Five European Countries. Frontiers in Public Health. 2017. Vol. 5, num. 44, pags. 1-9. ISSN 2296-2565. [consulted: 24 of August of 2026]. Available at: https://hdl.handle.net/2445/122829

Exportar metadades

JSON - METS

Compartir registre